 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- ||||| IMCY-0098 / Imcyse
Trial completion date, Trial termination, Trial primary completion date: IMCY-0098 Proof of ACtion in Type 1 Diabetes (IMPACT Study) (clinicaltrials.gov) - Jun 24, 2024
P2, N=110, Terminated, Sponsor: Imcyse SA
Trial completion date: Jan 2025 --> May 2024 | Active, not recruiting --> Terminated | Trial primary completion date: Jan 2025 --> Jan 2024; No efficacy at primary analysis after 1 year. Long term follow-up stopped
- | IMCY-0098 / Imcyse
Phase classification: IMCY-0098 Proof of ACtion in Type 1 Diabetes (IMPACT Study) (clinicaltrials.gov) - Feb 28, 2024
P2, N=110, Active, not recruiting, Sponsor: Imcyse SA
Long term follow-up stopped Phase classification: P2a --> P2
- || IMCY-0098 / Imcyse
Enrollment closed, Trial completion date, Trial primary completion date: IMCY-0098 Proof of ACtion in Type 1 Diabetes (IMPACT Study) (clinicaltrials.gov) - Mar 1, 2023
P2a, N=110, Active, not recruiting, Sponsor: Imcyse SA
Phase classification: P2a --> P2 Recruiting --> Active, not recruiting | Trial completion date: Sep 2024 --> Jan 2025 | Trial primary completion date: Sep 2024 --> Jan 2025
- || IMCY-0098 / Imcyse
Trial completion date, Trial primary completion date: IMCY-0098 Proof of ACtion in Type 1 Diabetes (IMPACT Study) (clinicaltrials.gov) - Jul 12, 2022
P2a, N=108, Recruiting, Sponsor: Imcyse SA
Recruiting --> Active, not recruiting | Trial completion date: Sep 2024 --> Jan 2025 | Trial primary completion date: Sep 2024 --> Jan 2025 Trial completion date: Apr 2023 --> Sep 2024 | Trial primary completion date: Apr 2023 --> Sep 2024
- | IMCY-0098 / Imcyse
Phase classification: IMCY-0098 Proof of ACtion in Type 1 Diabetes (IMPACT Study) (clinicaltrials.gov) - Jun 29, 2021
P2a, N=84, Recruiting, Sponsor: Imcyse SA
Trial completion date: Apr 2023 --> Sep 2024 | Trial primary completion date: Apr 2023 --> Sep 2024 Phase classification: P1/2 --> P2a
- ||| IMCY-0098 / Imcyse
Enrollment open: IMCY-0098 Proof of ACtion in Type 1 Diabetes (IMPACT Study) (clinicaltrials.gov) - Nov 29, 2020
P1/2, N=84, Recruiting, Sponsor: Imcyse SA
Phase classification: P1/2 --> P2a Not yet recruiting --> Recruiting
- |||| IMCY-0098 / Imcyse
New P1/2 trial: IMCY-0098 Proof of ACtion in Type 1 Diabetes (IMPACT Study) (clinicaltrials.gov) - Aug 23, 2020
P1/2, N=84, Not yet recruiting, Sponsor: Imcyse SA
- IMCY-0098 / Imcyse
[VIRTUAL] Long-term follow-up study of type 1 diabetes patients previously treated with IMCY-0098 or placebo in young adults with recent-onset type 1 diabetes (Graz Hall) - Jul 2, 2020 - Abstract #EASD2020EASD_357;
P1
The positive trend in clinical and immunological parameters improvement detected in the main study was not observed in the LTFU. The current data suggest that the right dosage or regimen (number and timing of injections of IMCY-0098) to elicit a significant and long-term effect is yet to be identified.
- || IMCY-0098 / Imcyse
Trial completion: IMCY-T1D-002: Long-term Follow-up Study of T1D Patients Previously Treated With IMCY-0098 or Placebo (clinicaltrials.gov) - Jan 15, 2020
P1, N=30, Completed, Sponsor: Imcyse SA
The current data suggest that the right dosage or regimen (number and timing of injections of IMCY-0098) to elicit a significant and long-term effect is yet to be identified. Recruiting --> Completed
- || IMCY-0098 / Imcyse
New P1 trial: IMCY-T1D-002: Long-term Follow-up Study of T1D Patients Previously Treated With IMCY-0098 or Placebo (clinicaltrials.gov) - Dec 8, 2019
P1, N=41, Recruiting, Sponsor: Imcyse SA
- | IMCY-0098 / Imcyse
Trial completion, Trial completion date: Study of IMCY-0098 in Patients With Recent Onset Type 1 Diabetes (clinicaltrials.gov) - Sep 6, 2019
P1, N=41, Completed, Sponsor: Imcyse SA
Recruiting --> Completed Active, not recruiting --> Completed | Trial completion date: Apr 2019 --> Aug 2019
- || IMCY-0098 / Imcyse
Enrollment closed: Study of IMCY-0098 in Patients With Recent Onset Type 1 Diabetes (clinicaltrials.gov) - Dec 3, 2018
P1, N=41, Active, not recruiting, Sponsor: Imcyse SA
Active, not recruiting --> Completed | Trial completion date: Apr 2019 --> Aug 2019 Recruiting --> Active, not recruiting
- | IMCY-0098 / Imcyse
Trial completion date, Trial primary completion date: Study of IMCY-0098 in Patients With Recent Onset Type 1 Diabetes (clinicaltrials.gov) - Oct 22, 2018
P1, N=40, Recruiting, Sponsor: Imcyse SA
Recruiting --> Active, not recruiting Trial completion date: Dec 2018 --> Apr 2019 | Trial primary completion date: Dec 2018 --> Apr 2019
- | IMCY-0098 / Imcyse
New P1 trial: Study of IMCY-0098 in Patients With Recent Onset Type 1 Diabetes (clinicaltrials.gov) - Sep 4, 2017
P1, N=40, Recruiting, Sponsor: Imcyse SA